NCT03673748View on ClinicalTrials.gov

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 27, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Lupus NephritisLupus Erythematosus
Interventions
DRUG

Mesenchymal stem cells (MSC)

Endovenous injection of MSV in saline solution

DRUG

Placebo

Endovenous injection of saline solution without cells

Trial Locations (1)

47012

RECRUITING

University Hospital Río Hortega, Valladolid

All Listed Sponsors
collaborator

Hospital del Rio Hortega

OTHER

collaborator

Hospital Clínico Universitario de Valladolid

OTHER

collaborator

University of Valladolid

OTHER

collaborator

Citospin

INDUSTRY

lead

Red de Terapia Celular

INDUSTRY